ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in Birmingham, AL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma
Cancer
Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Carcinoma
Ovarian Cancer
Lung Cancer

Pancreatic Cancer trials near Birmingham, AL, USA:

A Phase II Nationwide, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

This phase II study evaluates how well pemigatinib works for the treatment of adult patients with pancreatic cancer that has spread...

Enrolling
Metastatic Pancreatic Carcinoma
Stage IV Pancreatic Cancer AJCC v8
Drug: Pemigatinib
Procedure: Bone Scan

Phase 2

Sameek Roychowdhury

Birmingham, Alabama, United States and 70 other locations

Locations recently updated

to participants with locally advanced or metastatic solid tumors with certain KRAS mutations. LY4066434 will be given alone or in combinatio...

Enrolling
Advanced Solid Tumor
Non-small Cell Lung Cancer
Drug: Pembrolizumab
Drug: Irinotecan

Phase 1

Lilly
Lilly

Birmingham, Alabama, United States and 57 other locations

and Pharmacodynamic Study of Minnelide™Capsules given daily for 21 days followed by 7 days off schedule in patients with Advanced Solid Tumors...

Enrolling
Solid Tumor
Advanced Cancer
Drug: Minnelide™Capsules

Phase 1

Minneamrita Therapeutics

Birmingham, Alabama, United States and 6 other locations

* To evaluate the safety and tolerability of escalating doses of ERAS-007 in combination with other cancer therapies in study participants w...

Active, not recruiting
Metastatic Colorectal Cancer
Metastatic Pancreatic Ductal Adenocarcinoma
Drug: Cetuximab
Drug: ERAS-007

Phase 1, Phase 2

Erasca

Birmingham, Alabama, United States and 13 other locations

2 mutations. These include tumors in the colon or rectum, the uterus and the cervix (lower part of the uterus), the breast, the bladder, and...

Enrolling
Advanced Solid Tumors
HER2 Mutation
Drug: BAY2927088

Phase 2

Bayer
Bayer

Birmingham, Alabama, United States and 55 other locations

with gemcitabine, nab-paclitaxel (G-nP) or gemcitabine, nab-paclitaxel (G-nP) and atezolizumab in previously untreated subjects with metastatic pancreatic...

Enrolling
Pancreatic Ductal Adenocarcinoma (PDAC)
Drug: ProAgio Dose Levels (DL) 1,2,3,4
Drug: Gemcitabine, nab paclitaxel

Phase 1

ProDa BioTech

Birmingham, Alabama, United States

The purpose of this study is to find out whether the study drug, LY3537982, is safe and effective in cancer patients who have a specific gen...

Enrolling
Ovarian Neoplasms
Biliary Tract Neoplasms
Drug: Cetuximab
Drug: Cisplatin

Phase 1, Phase 2

Lilly
Lilly

Birmingham, Alabama, United States and 49 other locations

evaluate the safety, tolerability, drug levels, molecular effects, and clinical activity of MRTX849 (adagrasib) in patients with advanced solid tumors...

Active, not recruiting
Metastatic Cancer
Advanced Cancer
Drug: Cetuximab
Drug: Afatinib

Phase 1, Phase 2

Mirati Therapeutics
Mirati Therapeutics

Birmingham, Alabama, United States and 231 other locations

This clinical trial is evaluating a drug called ART0380 in participants with advanced or metastatic solid tumors. The main goals of this stu...

Enrolling
Endometrial Cancer
Metastatic Cancer
Drug: Irinotecan
Drug: ART0380

Phase 1, Phase 2

Artios Pharma

Birmingham, Alabama, United States and 71 other locations

This clinical trial is studying advanced solid tumors. Solid tumors are cancers that start in a part of your body like you...

Enrolling
Other Solid Tumors
Ovarian Neoplasms
Drug: PF-08052666

Phase 1

Seagen, a wholly owned subsidiary of Pfizer

Birmingham, Alabama, United States and 31 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems